A unique study tracking patient’s attitude and expectations in the Multiple Sclerosis Journey accross EU-5 countries.
MS Patient Treatment Monitor
20 000,00 €
France, Germany, Italy, Spain, UK
Pan European Dynamic and customisable dashboard – 50 questions – Sub-analyses.
Ad hoc online research. All MS Carenity’s community were invited to participate by email.
Annual subscription – 1 wave / year
Measure delays before prescription between first symptoms and MS suspicion / diagnosis / 1st prescription
Understand the treatment choice circumstances
Understand the MS patient’s attitude on treatment
Improve patients’ adherence and reduce treatement holidays
Optimize treatment switches